MichaelBigbyMDRosamariaCoronaDSc, MDDamianoAbeniMD, MPHPaoloPaolo PasquiniMD, MPHMoysesSzkloMD, MPH, DrPHHywelWilliamsMD
Copyright 2002 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2002
Question: In immunocompetent patients with
external genital warts, what are the benefits and the harms of imiquimod therapy?
Data Sources: Studies were identified through
a search of MEDLINE (1966-2000), the Cochrane Library (issue 3, 2000), and
PubMed (December 15, 2000). Reference lists of review articles were searched
for additional trials, and the manufacturers of 5% imiquimod cream were asked
about clinical trials. Authors of articles were not contacted for unpublished
reports or for additional information from published reports. No restrictions
to language were made.
Corona R. Systematic Review of Imiquimod for the Treatment of Genital Warts: All That Glitters Is Not Gold. Arch Dermatol. 2002;138(12):1599-1601. doi:10.1001/archderm.138.12.1599